ABSTRACT
CASO CLÍNICO: Presentamos el caso de una paciente de 19 años con un tumor vasoproliferativo, en cuya evolución presentó una membrana epirretiniana, edema macular, hemovítreo y desprendimiento de retina exudativo. Se trató con 3 inyecciones intravítreas de bevacizumab, implante intravítreo de dexametasona, tocilizumab y 2 sesiones de crioterapia. DISCUSIÓN: Las opciones terapéuticas son: observación en los de menor tamaño, periféricos y sin amenaza para la visión. Si se necesita tratamiento, fotocoagulación con láser, crioterapia transconjuntival, inyecciones intravítreas de bevacizumab, termoterapia transpupilar, terapia fotodinámica, placas de radioterapia y cirugía son diferentes opciones disponibles. Recientemente se ha descrito que el tocilizumab y los implantes intravítreos de dexametasona pueden ser beneficiosos
CASE REPORT: Here we report a 19-year-old female patient who presented a vasoproliferative tumour. It caused complications, such as epiretinal membrane, macular oedema, vitreous haemorrhage, and exudative retinal detachment. The patient was treated with 3 injections of intravitreal bevacizumab, an intravitreal dexamethasone implant, tocilizumab, and double freeze-thaw cryotherapy. DISCUSSION: Therapeutic options are: observation, if it is small, if it is a peripheral lesion, and if there seems to be no threat to vision. If it requires treatment, laser photocoagulation, intravitreal bevacizumab, trans-conjunctival cryotherapy, transpupillary thermotherapy, photodynamic therapy, brachytherapy plaques and surgery are the different options available. Recently, tocilizumab and intravitreal dexamethasone implants have been reported to be beneficial
Subject(s)
Humans , Female , Young Adult , Glioma/diagnostic imaging , Glioma/therapy , Retinal Neoplasms/therapy , Retinal Detachment/complications , Intravitreal Injections/methods , Cryotherapy , Retinal Telangiectasis/diagnostic imaging , Retinal Neoplasms/diagnostic imaging , Epiretinal Membrane/diagnosis , Epiretinal Membrane/therapy , Macular Edema/diagnosis , Macular Edema/therapy , Bevacizumab/therapeutic use , Dexamethasone , Laser Coagulation/methods , Visual Acuity , Retinal Telangiectasis/therapyABSTRACT
PURPOSE: Brilliant Blue G is used as a surgical adjuvant for retinal surgery. Although BBG double or multiple staining was reported, the effectiveness and safety of repeated staining is still elusive. To further examine the effectiveness and safety, we examined BBG in clinical cases in vivo, primary cell culture in vitro, and surgically resected specimen ex vivo. METHODS: A retrospective interventional case series with in vitro and ex vivo studies were performed. Vitrectomy was performed in 28 cases of epiretinal membrane with BBG single to multiple staining. The surgically resected membranes were stained by BBG with or without cellular fixation. Primary cell cultures were examined with BBG and live/death cell markers, such as Calcein AM and TUNEL. RESULTS: Single staining provided satisfactory staining in seven cases. Double or multiple staining substantially visualized internal limiting membrane (21 cases), especially the edges of remaining internal limiting membrane (11 cases). Adverse retinal staining was not noted and the final visual acuity showed no difference with multiple staining. The live cells barely stained with BBG, while some dead cells were stained. CONCLUSION: Brilliant Blue G multiple staining substantially enhanced the visualization of internal limiting membrane. The absence of abnormal staining supports the safety of repeated BBG staining.
Subject(s)
Basement Membrane/pathology , Epiretinal Membrane/surgery , Indicators and Reagents , Rosaniline Dyes , Animals , Basement Membrane/metabolism , Cell Survival , Cells, Cultured , Epiretinal Membrane/diagnosis , Epiretinal Membrane/metabolism , Fluoresceins/metabolism , Fluorescent Dyes/metabolism , Humans , In Situ Nick-End Labeling , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Permeability , Receptors, Purinergic P2X7/physiology , Retina/cytology , Retina/metabolism , Retrospective Studies , Staining and Labeling , Tomography, Optical Coherence , VitrectomyABSTRACT
PURPOSE: Spectral-domain optical coherence tomography (SD-OCT) is a noninvasive technique that can provide high-resolution images of macular morphology. The purpose of this study was to examine the pathological mechanism of uveitis and compare the changes in the macula of uveitis patients and the histopathological features of experimentally induced uveitis in mice. METHODS: Macular OCT was performed on 78 eyes of 51 patients of the Eye Hospital of Shandong University of Traditional Chinese Medicine, China, with apparent uveitis changes. C57BL/6 mice were injected with interphotoreceptor retinoid-binding protein (IRBP)-specific T cells from naïve mice immunized with complete Freund adjuvant IRBP(1-20) to induce uveitis. The disease was monitored by indirect fundoscopy. The eyes of the mice with experimental autoimmune uveitis (EAU) were enucleated 18 days after injection and classified according to pathological characteristics. RESULTS: The characteristics of uveitis were classified into six categories. Macular edema was detected in 48 eyes (61.5%); macular epiretinal membrane in 22 eyes (28.2%); choroidal neovascularization and macular lamellar holes in 4 eyes (5.1%), respectively; macular atrophy in 10 eyes (12.8%); and serous neuroepithelium detachment in 22 eyes (28.2%). As in human patients, pathological examinations of mouse EAU showed inflammation, folds, and atrophy of the outer part of the neuroretina, choroidal neovascularization with hemorrhagic retinal detachment, serous neuroepithelium detachment, and epiretinal membrane formation. CONCLUSIONS: Macular OCT of uveitis patients can display different morphological characteristics. Mouse EAU can simulate human uveitis. The comparative analysis of macular OCT in human uveitis and transfer EAU histopathology changes could provide important information on the pathogenesis of human uveitis.
Subject(s)
Disease Models, Animal , Macula Lutea/pathology , Tomography, Optical Coherence/methods , Uveitis/diagnosis , Adoptive Transfer , Adult , Animals , Choroidal Neovascularization/diagnosis , Epiretinal Membrane/diagnosis , Eye Proteins , Female , Fluorescein Angiography , Humans , Macular Edema/diagnosis , Male , Mice , Mice, Inbred C57BL , Middle Aged , Ophthalmoscopy , Retinal Detachment/diagnosis , Retinal Perforations/diagnosis , Retinol-Binding Proteins , T-Lymphocytes/immunology , Uveitis/immunologySubject(s)
Anesthesia, Local/adverse effects , Epiretinal Membrane/surgery , Eye Injuries, Penetrating/complications , Orbit/injuries , Retina/injuries , Vitrectomy/methods , Anesthesia, Local/methods , Cataract Extraction/methods , Epiretinal Membrane/diagnosis , Epiretinal Membrane/etiology , Eye Injuries, Penetrating/diagnosis , Female , Follow-Up Studies , Humans , Iatrogenic Disease , Middle Aged , Reoperation , Retina/pathologyABSTRACT
PURPOSE: The purpose of this study was to determine whether natural dyes facilitate posterior hyaloid detachment (posterior vitreous detachment [PVD]) and retinal internal limiting membrane (ILM) peeling in human eyes. METHODS: Open-sky vitrectomy with posterior hyaloid and ILM removal was performed in 86 human cadaveric eyes. After core vitrectomy, 11 different dyes were injected into the vitreous cavity to aid hyaloid detachment and ILM removal. The dyes were allowed to settle on the macula for 5 minutes after PVD and were removed by mechanical aspiration. Intraocular forceps were used for ILM peeling, which was confirmed by light microscopy of the peeled tissue. Acai fruit (Euterpe oleracea) extract and 10 additional dyes from plants or animal sources were tested: pomegranate (Punica granatum), logwood (Haematoxylum campechianum), chlorophyll extract from alfalfa (Medicago sativa), cochineal (Dactylopius coccus), hibiscus (Hibiscus rosa-sinensis), indigo (Indigofera tinctoria), paprika (Capiscum annuum), turmeric (Curcuma longa), old fustic (Maclura tinctoria), and grape (Vitis vinifera). RESULTS: The dyes facilitated PVD and ILM peeling. Acai fruit (E. oleracea) extract, logwood (H. campechianum), cochineal (D. coccus), and old fustic (M. tinctoria) facilitated PVD in all cases; dye-assisted PVD was compared with triamcinolone-assisted PVD performed previously in a comparative model. Acai fruit (E. oleracea) extract, cochineal (D. coccus), and chlorophyll extract from alfalfa (M. sativa) showed the best capability for ILM staining; dye-assisted ILM removal was compared with the ILM peeling guided by indocyanine green staining performed previously in a comparative model. Light microscopy confirmed the ILM removal in all cases. CONCLUSION: Anthocyanin dye of the acai fruit (E. oleracea) and the dyes from cochineal (D. coccus) and chlorophyll extract from alfalfa (M. sativa) resulted in the best capability for posterior hyaloid and ILM staining in human cadaveric eyes and may be a useful tool for vitreoretinal surgery.
Subject(s)
Anthocyanins/administration & dosage , Arecaceae/chemistry , Epiretinal Membrane/surgery , Fruit/chemistry , Pigments, Biological/administration & dosage , Vitreous Detachment/surgery , Basement Membrane/surgery , Cadaver , Chromatography, High Pressure Liquid , Epiretinal Membrane/diagnosis , Humans , Plant Extracts/chemistry , Spectrometry, Mass, Electrospray Ionization , Staining and Labeling/methods , Suction , Tissue Donors , Vitrectomy , Vitreous Detachment/diagnosisABSTRACT
PURPOSE: To describe the clinical appearance and the visual outcome of a cohort of patients with vasoproliferative retinal tumours (VPRTs) that were diagnosed and treated between 2002 and 2007 at the University Hospital of Örebro. METHODS: Nine patients with diagnosed VPRTs were included in a retrospective study. The mean age at the time of diagnosis was 50.2 years (range 7-74 years). Follow-up time ranged between 14 and 83 months (mean 42.6). Nine out of ten eyes received cryotherapy; six eyes were also treated with photocoagulation. One patient was treated with intravitreal injections of ranibizumab (Lucentis(®)) and another was referred for brachytherapy. Because of persisting macular oedema, one eye was treated with intravitreal injection of triamcinolon. RESULTS: Of the treated eyes, one had anterior uveitis, six had macular oedema at baseline and four had an exudative retinal detachment at the time of diagnosis. Seven eyes underwent vitrectomy because of epiretinal membranes. Visual acuity at diagnosis was 0.21 (mean) (range 0.02-0.6) and at latest check-up 0.30 (mean) (range light perception (LP)-1.0), with improvement in six eyes and deterioration in two. Two out of four patients with retinal detachment were successfully treated surgically. CONCLUSION: VPRTs are benign intraretinal changes. Several complications are associated with this condition. All patients in this study had symptom-giving tumours and six patients (six eyes) already had profound macular oedema at presentation. In these cases, when complications have already developed, the final visual prognosis is poor, thereby making it important to detect these tumours early. The patient who received anti-vascular endothelial growth factor (VEGF; Lucentis) therapy showed a slow improvement and distinct regression in exudations during the follow-up time. However, no increase in visual acuity was seen. At latest examination a peripheral exudative retinal detachment was still observed. Whether anti-VEGF treatment is effective, as either an alternative or complementary therapy, must be established in the future.
Subject(s)
Hemangioma/pathology , Retinal Neoplasms/pathology , Adolescent , Adult , Aged , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Brachytherapy , Child , Cryotherapy , Epiretinal Membrane/diagnosis , Follow-Up Studies , Hemangioma/epidemiology , Hemangioma/therapy , Humans , Laser Coagulation , Macular Edema/diagnosis , Middle Aged , Ranibizumab , Retinal Neoplasms/epidemiology , Retinal Neoplasms/therapy , Retrospective Studies , Sweden/epidemiology , Tomography, Optical Coherence , Visual Acuity/physiology , VitrectomyABSTRACT
PURPOSE: To investigate the effects of intravitreal brilliant blue G (BBG) on the morphology and functions of the retina and its possible use for staining and peeling of the internal limiting membrane (ILM). METHODS: Rat eyes (n = 78) underwent gas compression vitrectomy. BBG solution was then injected into the vitreous cavity. The eyes were enucleated at 2 weeks and 2 months. Light as well as electron microscopy, terminal nick-end labeling staining, and electroretinography (ERG) were used to investigate retinal damage and function. To test the clinical potential of BBG, ILM staining was evaluated in primate eyes after pars plana vitrectomy followed by ILM peeling. RESULTS: In the rat eyes, no pathologic changes were observed with light microscopy. Electron microscopy revealed that high doses of BBG induced vacuolization in the inner retinal cells, but apoptosis was not detected. There was no reduction in the amplitude of the ERG waves. In the primate eyes, the ILM was clearly visualized after the intravitreous injection of BBG and was peeled off easily from the retina. CONCLUSIONS: These results demonstrate that BBG, which has low potential for toxicity, high staining ability, and ease of handling, is a good candidate dye for ILM peeling.
Subject(s)
Coloring Agents/toxicity , Epiretinal Membrane/surgery , Retina/drug effects , Rosaniline Dyes/toxicity , Animals , Apoptosis , Basement Membrane/pathology , Basement Membrane/surgery , Drug Evaluation, Preclinical , Electroretinography , Epiretinal Membrane/diagnosis , Fluorescein Angiography , In Situ Nick-End Labeling , Injections , Macaca fascicularis , Male , Microscopy, Electron , Rats , Rats, Inbred BN , Retina/physiology , Retina/ultrastructure , Retinal Diseases/chemically induced , Retinal Diseases/pathology , Staining and Labeling/methods , Vitrectomy , Vitreous Body/drug effectsSubject(s)
Coloring Agents , Epiretinal Membrane/surgery , Retinal Perforations/surgery , Rosaniline Dyes , Animals , Basement Membrane/pathology , Basement Membrane/surgery , Coloring Agents/adverse effects , Coloring Agents/toxicity , Drug Evaluation, Preclinical , Epiretinal Membrane/diagnosis , Humans , Indocyanine Green/adverse effects , Retina/drug effects , Retinal Diseases/chemically induced , Retinal Perforations/diagnosis , Rosaniline Dyes/adverse effects , Rosaniline Dyes/toxicityABSTRACT
BACKGROUND: Presently the indication for transpupillary thermotherapy (TTT) is the treatment of retrofoveal occult subretinal neovascular membranes (OSRNM) for which PDT (photodynamic therapy) has a limited effect. The diode laser power settings given by the manufacturer (Iridex Co, Mountain View, California) have to be modulated according to several criteria including patient pigmentation. The purpose here was to report on a group of patients that presented chorioretinal atrophy after TTT. METHODS: Thirty-eight eyes of 37 patients with OSRNM due to age-related macular degeneration underwent TTT. Indications to treat were diffuse exudative membranes, limited subfoveal OSRNM with a visual acuity of less than 0.4, or a drop of visual acuity of 3 Snellen lines or more since the previous examination. Dual fluorescein and indocyanine green angiography were used for angiographic follow-up. Treatment was performed according to the manufacturer's parameters. The group of patients that presented chorioretinal atrophy after TTT was analysed in this study RESULTS: Five patients presented a limited or spot-size related post-TTT chorioretinal atrophy. Pre-laser visual acuity was 0.34 +/- 0.13 and post-TTT visual acuity was 0.25 +/- 0.15. The OSRNM had disappeared in all cases. The common denominator in these patients was that they were white haired but upon questioning all happened to be dark-haired in their youth. CONCLUSIONS: Evolution towards atrophy can occur after TTT and probably depends on several factors. We showed that pigmentation is a parameter to be evaluated carefully before TTT and that laser power settings should progressively be diminished with increasing patient pigmentation. In white haired persons the original pigmentary status should be part of the patient history.